Abstract Objective To study the pathogen composition and antimicrobial resistance characteristics in neonates with sepsis in the Hebei area, providing a basis for optimizing the management strategies for neonatal sepsis in the region. Methods The medical data of neonates with sepsis confirmed by blood culture from 23 hospitals in Hebei Province were collected prospectively from November 1, 2021 to December 31, 2022. The pathogen composition and antimicrobial resistance characteristics were analyzed in early-onset sepsis (EOS), community-acquired late-onset sepsis (CALOS), and hospital-acquired late-onset sepsis (HALOS) cases. Results A total of 289 neonates were included, accounting for 292 infection episodes, with 117 (40.1%) EOS, 95 (32.5%) CALOS, and 80 (27.4%) HALOS cases. A total of 294 pathogens were isolated, with 118 (40.1%) from the EOS group, where Escherichia coli (39 strains, 33.0%) and coagulase-negative staphylococci (13 strains, 11.0%) were the most common. In the CALOS group, 95 pathogens were isolated (32.3%), with Escherichia coli (35 strains, 36.8%) and group B Streptococcus (14 strains, 14.7%) being predominant. The HALOS group yielded 81 isolates (27.6%), with Klebsiella pneumoniae (24 strains, 29.6%) and Escherichia coli (21 strains, 25.9%) as the most frequent. Coagulase-negative staphylococci showed over 80% resistance to penicillin antibiotics. Escherichia coli and Klebsiella pneumoniae showed a resistance rate of 2.2% to 75.0% to common β-lactam antibiotics. The resistance rates of predominant Gram-negative bacteria in the HALOS group to common β-lactam antibiotics were higher than those in the CALOS group. Conclusions In the Hebei region, Escherichia coli is the most common pathogen in both EOS and LOS. There are differences in the composition and antimicrobial resistance of pathogens among different types of neonatal sepsis. The choice of empirical antimicrobial drugs should be based on the latest surveillance data from the region.
Corresponding Authors:
(Ma L, Email:18503292173@163.com)
E-mail: 18503292173@163.com
Cite this article:
Hebei Neonatal Sepsis Research Group. A cross-sectional study on the pathogen composition and antimicrobial resistance in neonates with sepsis in Hebei Province, China[J]. CJCP, 2024, 26(4): 350-357.
Hebei Neonatal Sepsis Research Group. A cross-sectional study on the pathogen composition and antimicrobial resistance in neonates with sepsis in Hebei Province, China[J]. CJCP, 2024, 26(4): 350-357.
Stoll BJ, Gordon T, Korones SB, et al. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network[J]. J Pediatr, 1996, 129(1): 72-80. PMID: 8757565. DOI: 10.1016/s0022-3476(96)70192-0.
Stoll BJ, Hansen N, Fanaroff AA, et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants[J]. N Engl J Med, 2002, 347(4): 240-247. PMID: 12140299. DOI: 10.1056/NEJMoa012657.
Puopolo KM, Lynfield R, Cummings JJ, et al. Management of infants at risk for group B streptococcal disease[J]. Pediatrics, 2019, 144(2): e20191881. PMID: 31285392. DOI: 10.1542/peds.2019-1881.
Liu J, Fang Z, Yu Y, et al. Pathogens distribution and antimicrobial resistance in bloodstream infections in twenty-five neonatal intensive care units in China, 2017-2019[J]. Antimicrob Resist Infect Control, 2021, 10(1): 121. PMID: 34399840. PMCID: PMC8365905. DOI: 10.1186/s13756-021-00989-6.
Giannoni E, Agyeman PKA, Stocker M, et al. Neonatal sepsis of early onset, and hospital-acquired and community-acquired late onset: a prospective population-based cohort study[J]. J Pediatr, 2018, 201: 106-114.e4. PMID: 30054165. DOI: 10.1016/j.jpeds.2018.05.048.
Ding Y, Wang Y, Hsia Y, et al. Systematic review and meta-analyses of incidence for group B Streptococcus disease in infants and antimicrobial resistance, China[J]. Emerg Infect Dis, 2020, 26(11): 2651-2659. PMID: 33079042. PMCID: PMC7588546. DOI: 10.3201/eid2611.181414.
Russell NJ, Seale AC, O'Driscoll M, et al. Maternal colonization with group B Streptococcus and serotype distribution worldwide: systematic review and meta-analyses[J]. Clin Infect Dis, 2017, 65(suppl_2): S100-S111. PMID: 29117327. PMCID: PMC5848259. DOI: 10.1093/cid/cix658.
Tessema B, Lippmann N, Knüpfer M, et al. Antibiotic resistance patterns of bacterial isolates from neonatal sepsis patients at university hospital of Leipzig, Germany[J]. Antibiotics (Basel), 2021, 10(3): 323. PMID: 33808878. PMCID: PMC8003699. DOI: 10.3390/antibiotics10030323.
Flannery DD, Akinboyo IC, Mukhopadhyay S, et al. Antibiotic susceptibility of Escherichia coli among infants admitted to neonatal intensive care units across the US from 2009 to 2017[J]. JAMA Pediatr, 2021, 175(2): 168-175. PMID: 33165599. PMCID: PMC7653538. DOI: 10.1001/jamapediatrics.2020.4719.
Gao K, Fu J, Guan X, et al. Incidence, bacterial profiles, and antimicrobial resistance of culture-proven neonatal sepsis in South China[J]. Infect Drug Resist, 2019, 12: 3797-3805. PMID: 31819560. PMCID: PMC6899077. DOI: 10.2147/IDR.S223597.
Cotten CM, Taylor S, Stoll B, et al. Prolonged duration of initial empirical antibiotic treatment is associated with increased rates of necrotizing enterocolitis and death for extremely low birth weight infants[J]. Pediatrics, 2009, 123(1): 58-66. PMID: 19117861. PMCID: PMC2760222. DOI: 10.1542/peds.2007-3423.
Navon-Venezia S, Kondratyeva K, Carattoli A. Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance[J]. FEMS Microbiol Rev, 2017, 41(3): 252-275. PMID: 28521338. DOI: 10.1093/femsre/fux013.
LI Shu-Juan, HU Li-Yuan, ZHANG Rong, YANG Lin, XI Li, LIU Fang, CAO Yun, ZHOU Wen-Hao, CHENG Guo-Qiang. Acute heart failure in a neonate[J]. CJCP, 2024, 26(3): 321-324.
[5]
Guideline Development Group of Clinical Practice Guidelines for Meropenem Therapy in Neonatal Sepsis; PekingUniversity Third Hospital; Editorial Department of Chinese Journal of Contemporary Pediatric. Clinical practice guidelines for meropenem therapy in neonatal sepsis (2024)[J]. CJCP, 2024, 26(2): 107-117.
